Last reviewed · How we verify

NCT05543408: CON-VIDA

Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"

Status unknown NA Last updated 22 September 2022
What this trial tests

NA trial testing EXERCISE in COVID-19 in 40 participants. Status unknown.

Timeline
3 May 2022
Primary endpoint
2 August 2022
31 October 2022

Quick facts

Lead sponsorUniversidad San Jorge
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date3 May 2022
Primary completion2 August 2022
Estimated completion31 October 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad San Jorge

Who can join

Adults 18 to 65, any sex, with COVID-19 or Long COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled trial of the efficacy of an individualized, progressive, exercise program (strength, cardiovascular, and breathing exercises) in recovering people from the post-COVID-19 syndrome (i.e., patients who present symptoms \>12 weeks once the acute phase of the disease is over).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of EXERCISE

Trials testing the same drug.

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other Universidad San Jorge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05543408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing